Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"b cell engineering"”.
-
Development of adeno-associated virus capsid libraries tailored towards B cell engineering applications
… approaches for generating primary human B cells expressing monoclonal antibodies require extensive ex vivo manipulation and are unsuitable for large-scale clinical application. Furthermore, existing B cell engineering strategies were developed for infectious disease applications and require …
-
Engineering B-Cells for Antibody Production: Exploring Germinal Center Formation Capacity and Transfection Potential Via Nanowires
… to induce long-term protection by editing B-cells to produce neutralizing antibodies targeted against these viruses. Building upon a previously established CRISPR model by Moffett et al. (2019), this study aimed to enhance the process involved in engineering B-cells for RSV. To explore …
-
INVESTIGATION OF SUCCINYLATED ZWITTERIONIC POLYETHYLENIMINE/DNA COMPLEXES: PERFORMANCE IN SERUM, INTERNALIZATION, AND INTRACELLULAR FATE
… is effective at delivering nucleic acids to cells, but is associated with dangerous immunogenic responses and cancer-causing insertions into the genome. Viral vectors are also among the most prohibitively costly therapeutics in medicine. Polymeric vectors avoid these dangers and are made from …
-
Towards new passive and active vaccine design strategies that target the interaction with viral entry receptors
… regular administration. Newer approaches of cellular vaccines, such as engineering of B cells, aim at replacing native B cell receptor sequences ex vivo with those of known neutralizing antibodies. Upon reinjection, modified B cells differentiate into long-lasting plasma cells expressing …
-
Modulating antigen-specific humoral immunity with non-differentiating B cells
… central role as producers of serum antibody, B cells also exhibit many unique properties that could be exploited in cell therapy applications, notably including antigen-specific recognition and the linked capacity for antigen presentation. Here we employed CRISPR/Cas9 to demonstrate that ex vivo …